Nova Leap Health Corp. NVLPF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 19.63% | -2.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.63% | -2.92% | |||
| Cost of Revenue | 18.80% | -3.03% | |||
| Gross Profit | 20.89% | -2.74% | |||
| SG&A Expenses | 5.97% | -2.63% | |||
| Depreciation & Amortization | 20.16% | -23.30% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.26% | -3.39% | |||
| Operating Income | 159.17% | 11.19% | |||
| Income Before Tax | 94.00% | 812.21% | |||
| Income Tax Expenses | 78.47% | 1,379.41% | |||
| Earnings from Continuing Operations | 100.25% | 704.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 100.25% | 704.47% | |||
| EBIT | 159.17% | 11.19% | |||
| EBITDA | 112.09% | 14.70% | |||
| EPS Basic | 100.00% | 716.67% | |||
| Normalized Basic EPS | 96.97% | 925.00% | |||
| EPS Diluted | 89.19% | 716.67% | |||
| Normalized Diluted EPS | 93.94% | 925.00% | |||
| Average Basic Shares Outstanding | 0.00% | -3.66% | |||
| Average Diluted Shares Outstanding | 0.30% | -2.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||